PDG29 ORPHAN DRUGS ASSESMENT IN FRANCE: ACCEPTABILITY OF THE CLINICAL DATA FOR THE ECONOMIC EVALUATION
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1043
https://www.valueinhealthjournal.com/article/S1098-3015(19)33421-7/fulltext
Title :
PDG29 ORPHAN DRUGS ASSESMENT IN FRANCE: ACCEPTABILITY OF THE CLINICAL DATA FOR THE ECONOMIC EVALUATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33421-7&doi=10.1016/j.jval.2019.09.1043
First page :
Section Title :
Open access? :
No
Section Order :
10918